ISBT on Age-Appropriate Platelet Transfusion Thresholds: New Insights from the 2025 AABB Guidelines
International Society of Blood Transfusion (ISBT) shared an enlightening post on LinkedIn:
“DID YOU KNOW? A new series by the Pediatric Subgroup of the Clinical Transfusion Working Party
In neonates, platelet transfusion thresholds are often higher than in adults due to immature hemostatic systems and a greater risk of bleeding.
Preterm infants may require platelet counts of 25,000–50,000/μL, depending on clinical condition, while stable adults typically require only 10,000–20,000/μL.
According to the 2025 AABB Guidelines, a restrictive threshold of 25,000/μL is now considered safer than the previously used liberal 50,000/μL threshold, which may increase risk.
This highlights the importance of age-appropriate transfusion strategies that reflect the unique physiology of neonates.
Reference: Metcalf RA, Nahirniak S, Guyatt G, et al. Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines. JAMA. 2025. doi:10.1001/jama.2025.7529”
Find the reference here:
Follow the newest insights in platelet science with Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID